the central mg ios dn bfg

Upload: kellie-pacanowski

Post on 04-Jun-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 The Central Mg Ios Dn Bfg

    1/3

  • 8/13/2019 The Central Mg Ios Dn Bfg

    2/3

    wheezing, shortness of breath, chest tightness and coughing. Some side effects of this drug are

    headaches, fever, or muscle pain. Salmeterol is used in combination with other drugs for the long

    term control of asthma, it may also be used to prevent breathing issues in those with nocturnal

    asthma or exercise related breathing problems. This drug works by widening the airways in the

    lungs allowing patients to breathe more easily. Salmeterol or Serevent Diskus currently only

    appears in the form of a DPI. Never prescribe salmeterol in large doses because of the risk of

    very serious heart problems such as irregular heartbeat, salmeterol may not be the best option for

    diabetics because it can negatively affect blood sugar. Arformoterol or Brovana is a long acting

    adrenergic bronchodilator used in the treatment of chronic bronchitis and emphysema. Brovana

    is administered by a SVN and should be given twice a day, 12 hours apart. Brovana cannot be

    used to treat sudden COPD attacks, but instead controls symptoms of COPD. Although your

    patient may try to convince you that the drug has cured their disease this is not the result.

    Brovana like the former drugs opens up the airways allowing easier breathing.

    A sympathomimetic drug causes stimulation of the sympathetic nervous system by

    mimicking the actions of epinephrine which can cause tachycardia, elevated blood pressure, and

    smooth muscle relaxation of bronchioles. Examples of sympathomimetic drugs are Formoterol

    and Pirbuterol. Formoterol is a long acting drug used for the maintenance of bronchodilation, and

    control of bronchospasm. Formoterol is only prescribed if a patientsasthma is so severe that two

    medications will be needed to control it. Formoterol helps to prevent an asthma or COPD attack

    but will not stop an attack that has already begun. Pirbuterol is used to treat wheezing and

    shortness of breath occurring with asthma and COPD. This drug comes in the form of an inhaler

    which allows the drug to reach far into the lungs for the most possible benefit. Pirbuterol will not

  • 8/13/2019 The Central Mg Ios Dn Bfg

    3/3

    and should not be prescribed if the patient is using another short acting sympathomimetic

    bronchodilator such as Albuterol.

    A parasympatholytic drug is a drug that blocks the parasympathetic nervous fibers. These

    drugs work to treat bradycardias, bradydysrhythmias and treat illnesses causing the bronchioles

    to constrict such as asthma. A drug falling under the parasympatholytic classification is

    Tiotropium bromide. Tiotropium bromide or Spiriva is a long acting 24 hour bronchodilator used

    to control the symptoms of COPD. Spiriva can reduce COPD flare-ups due to the improvement

    of lung function from opening the airways. Spiriva is not a rescue inhaler and should not be used

    as one; however patients who use Spiriva have been shown to use their rescue inhalers less often.

    Since Spiriva appears in a powder form, be sure to warn patients of the possible side effect of

    blurred vision or temporary blindness should the medication contaminate the eye.

    It is important to know the understand why certain drugs should not be used in a patient,

    for example, a patient may be admitted who is suffering from an asthma attack and also has

    retained secretions, in a situation such as this a parasympatholytic drug should not be

    administered because parasympatholytic drugs have been found to dry secretions, even though

    they will offer bronchodilation. Be sure to check patient charts before blindly administering a

    drug, our job is to support the patient during their time of need, and to help them return to normal

    function, or at least their normal. Understanding the nervous system in correlation to respiratory

    care based on the control mechanisms and physiological effects will form the basis for

    knowledge of drug actions and drug effects of drugs that we one day will be asked to administer

    or recommend for a patient.